SMTL ID : 9bfw.1

Tri-complex of Compound-4, KRAS G12C, and CypA

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.20 Å

Oligo State

hetero-1-1-mer

Ligands

1 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)

GNP.1: 23 residues within 4Å: Chain A: A.12, C.13, G.14, V.15, G.16, K.17, S.18, A.19, F.29, V.30, D.31, Y.33, P.35, T.36, N.117, K.118, D.120, L.121, S.146, A.147, K.148 Ligands: MG.2, 01.4 22 PLIP interactions: 22 interactions with chain A Hydrogen bonds: A:G.14, A:V.15, A:G.16, A:K.17, A:K.17, A:S.18, A:S.18, A:A.19, A:V.30, A:T.36, A:N.117, A:K.118, A:K.118, A:A.147, A:K.148 Water bridges: A:G.11, A:K.17, A:S.18, A:T.36 Salt bridges: A:D.120 pi-Stacking: A:F.29, A:F.29

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: S.18, T.36 Ligands: GNP.1 4 PLIP interactions: 2 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:S.18, A:T.36, H2O.2, H2O.2

1 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)

BTB.3: 3 residues within 4Å: Chain A: T.125, D.127, Q.130 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.125, A:Q.130 Salt bridges: A:D.127

1 x 01: 1-acetyl-N-[(2S)-1-{[(1M,8S,10R,14S,20S)-22-cyano-4-hydroxy-18,18-dimethyl-9,15-dioxo-16-oxa-10,20,28-triazapentacyclo[18.5.2.1~2,6~.1~10,14~.0~23,27~]nonacosa-1(25),2(29),3,5,21,23,26-heptaen-8-yl]amino}-3-methyl-1-oxobutan-2-yl]-N-methylazetidine-3-carboxamide (non-preferred name)

01.4: 23 residues within 4Å: Chain A: C.13, Y.33, P.35, T.36, I.37, A.60, G.61, Y.65, M.68, R.69, Y.72 Chain B: R.56, M.62, Q.64, G.73, A.102, N.103, A.104, Q.112, F.114, L.123, H.127 Ligands: GNP.1 20 PLIP interactions: 12 interactions with chain B, 8 interactions with chain A Hydrophobic interactions: B:A.102, B:F.114, B:L.123, A:I.37, A:A.60, A:Y.65, A:Y.65, A:Y.65, A:M.68 Hydrogen bonds: B:R.56, B:R.56, B:Q.64, B:Q.64, B:N.103, B:N.103, A:Y.33, A:T.36 Water bridges: B:G.105 Salt bridges: B:R.56 pi-Cation interactions: B:R.56

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cregg, J. et al., Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers. J.Med.Chem. (2025)

Release Date

2025-03-05

Peptides

GTPase KRas: A
Peptidyl-prolyl cis-trans isomerase A: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
D

GTPase KRas

Peptidyl-prolyl cis-trans isomerase A

Related Entries With Identical Sequence